Clinical Trial Update: 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating 5-hydroxytryptophan and creatine for treatment-resistant depression associated with hypoxia in females has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• 5-Hydroxytryptophan (5-HTP)
• Creatine (creatine)

Snippet

Sponsor: Perry Renshaw | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-01-04